GF Fund Management CO. LTD. Purchases New Position in Danaher Co. (NYSE:DHR)

GF Fund Management CO. LTD. bought a new position in Danaher Co. (NYSE:DHR - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 16,033 shares of the conglomerate's stock, valued at approximately $3,680,000.

Other institutional investors have also recently bought and sold shares of the company. Gilbert & Cook Inc. boosted its position in shares of Danaher by 2.5% in the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate's stock valued at $401,000 after acquiring an additional 42 shares during the period. Grimes & Company Inc. raised its stake in Danaher by 0.6% during the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate's stock valued at $1,696,000 after purchasing an additional 43 shares during the last quarter. Spinnaker Trust boosted its holdings in Danaher by 1.2% in the 4th quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate's stock valued at $988,000 after purchasing an additional 50 shares during the period. Fortis Capital Advisors LLC grew its position in Danaher by 1.3% in the 4th quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate's stock worth $914,000 after purchasing an additional 50 shares during the last quarter. Finally, Fayez Sarofim & Co increased its holdings in shares of Danaher by 0.6% during the 4th quarter. Fayez Sarofim & Co now owns 8,287 shares of the conglomerate's stock worth $1,902,000 after purchasing an additional 50 shares during the period. Institutional investors own 79.05% of the company's stock.

Analysts Set New Price Targets

Several research firms recently weighed in on DHR. Citigroup reiterated a "buy" rating on shares of Danaher in a research note on Monday, April 7th. JPMorgan Chase & Co. cut their price target on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Jefferies Financial Group decreased their price objective on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. The Goldman Sachs Group lowered their price objective on Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. Finally, Robert W. Baird reduced their target price on Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, Danaher presently has an average rating of "Moderate Buy" and a consensus price target of $263.24.

Insider Buying and Selling

In related news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.20% of the stock is owned by corporate insiders.

Danaher Price Performance

Shares of NYSE DHR traded down $1.83 during mid-day trading on Friday, hitting $188.64. 1,045,225 shares of the stock were exchanged, compared to its average volume of 3,463,450. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The stock's fifty day simple moving average is $193.18 and its two-hundred day simple moving average is $214.13. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a market cap of $135.01 billion, a P/E ratio of 35.72, a PEG ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. As a group, analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.68%. Danaher's dividend payout ratio (DPR) is 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.